KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Gains from Sales and Divestitures (2016)

Historic Gains from Sales and Divestitures for AbbVie (ABBV) over the last 4 years, with Q2 2016 value amounting to $6.1 million.

  • AbbVie's Gains from Sales and Divestitures rose 1115.54% to $6.1 million in Q2 2016 from the same period last year, while for Jun 2016 it was $6.1 million, marking a year-over-year increase of 1115.54%. This contributed to the annual value of $5.7 million for FY2015, which is 1410.06% down from last year.
  • As of Q2 2016, AbbVie's Gains from Sales and Divestitures stood at $6.1 million, which was up 1115.54% from $5.5 million recorded in Q1 2016.
  • AbbVie's Gains from Sales and Divestitures' 5-year high stood at $7.6 million during Q4 2013, with a 5-year trough of $5.3 million in Q1 2015.
  • For the 4-year period, AbbVie's Gains from Sales and Divestitures averaged around $6.4 million, with its median value being $6.3 million (2014).
  • In the last 5 years, AbbVie's Gains from Sales and Divestitures crashed by 1453.25% in 2015 and then soared by 1115.54% in 2016.
  • AbbVie's Gains from Sales and Divestitures (Quarter) stood at $7.6 million in 2013, then fell by 12.11% to $6.6 million in 2014, then decreased by 14.1% to $5.7 million in 2015, then rose by 7.65% to $6.1 million in 2016.
  • Its Gains from Sales and Divestitures was $6.1 million in Q2 2016, compared to $5.5 million in Q1 2016 and $5.7 million in Q4 2015.